We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Silicone Breast Implants Associated with Rare Diseases

By HospiMedica International staff writers
Posted on 26 Sep 2018
Print article
Image: Silicone and saline breast implants shown side by side (Photo courtesy of Science Photo Library).
Image: Silicone and saline breast implants shown side by side (Photo courtesy of Science Photo Library).
A new study reveals that silicone implants are associated with rare diseases, autoimmune disorders, and other conditions, although a causative relationship was not established.

Researchers at the University of Texas MD Anderson Cancer Center (MD Anderson; Houston, USA) conducted a multicenter cohort study that analyzed large post-approval studies (LPAS) initiated by the U.S. Food and Drug Administration (FDA) in order to monitor long-term implant-related outcomes and systemic harms of silicone and saline breast implants placed during primary, revision, augmentation, or reconstruction surgery. Systemic harms, self-harm, reproductive outcomes, and implant-related complications were analyzed by implant composition and operative indication.

LPAS data was available for 99,993 patients, with 56% of the implants made of silicone. Silicone implants were associated with higher rates of Sjogren syndrome, scleroderma, rheumatoid arthritis, stillbirth, and melanoma. The study found no correlation between breast implants and suicide or fibromyalgia. There were higher patient-reported rates of stillbirth, preterm birth, and neonatal intensive care unit (nICU) admittance, but no association with miscarriage. Lower self-reported rate of birth defects or congenital malformation were found among women with silicone implants.

Regarding short-term outcomes, rupture was significantly higher for saline implants (2.5% versus 0.5%), while capsular contracture was higher for silicone ones (5% versus 2.8%). At seven years from primary augmentation, the overall reoperation rate stood at 11.7%, while for revision breast reconstruction the reoperation rate was 25%. One case of breast implant associated with anaplastic large cell lymphoma was reported. Capsular contracture occurred in 7.2% of primary augmentations and 12.7% of primary reconstructions. The study was published on September 18, 2018, in Annals of Surgery.

“All surgical procedures and implantable devices have potential complications and side effects. As plastic surgeons, it’s our responsibility to continually monitor the long-term safety of breast implants and make sure that all patients and physicians are aware of any possible adverse outcomes,” said senior author Mark Clemens, MD. “It’s vital that women with implants be aware of the potential risks, so they can identify symptoms early and consult with their doctors. Fortunately, many of the diseases and conditions that have an association with implants are quite rare, so awareness is that much more important.”

A breast implant is a prosthesis used to change the size, shape, and contour of a woman’s breast. There are two general types of breast implant devices, defined by their filler. Saline implants are composed of an elastomer silicone shell filled with sterile saline solution during surgery; the silicone implant has an elastomer silicone shell pre-filled with viscous silicone gel. The two approved manufacturers of silicone gel-filled breast implants in the United States are Allergan (Irvine, CA, USA) and Mentor (Santa Barbara, CA, USA).

Related Links:
University of Texas MD Anderson Cancer Center
Allergan
Mentor

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Diagnostic Display System
C3MPL

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.